“…Earlier reports showed that the AMORE strategy is an effective local treatment modality in HNRMS patients, with survival figures comparable to other international study groups. [9][10][11][12][13][14] The purpose of this study was to evaluate the longterm hearing loss in survivors of paediatric HNRMS. We performed audiological examinations in survivors treated at four large paediatric oncology centres: Great Ormond Street Hospital (GOSH), London, the Royal Marsden Hospital (RMH), Sutton, University College London Hospitals (UCLH), London, and the Emma Children's Hospital-Academic Medical Centre (EKZ-AMC), Amsterdam.…”